Loading...
XJPX7731
Market cap3.62bUSD
Dec 24, Last price  
1,639.50JPY
1D
-0.06%
1Q
10.93%
Jan 2017
-9.77%
Name

Nikon Corp

Chart & Performance

D1W1MN
XJPX:7731 chart
P/E
17.45
P/S
0.79
EPS
93.96
Div Yield, %
3.05%
Shrs. gr., 5y
-2.61%
Rev. gr., 5y
0.24%
Revenues
717.25b
+14.19%
638,468,000,000730,943,000,000822,813,000,000955,791,000,000879,719,000,000785,498,000,000887,512,000,000918,651,000,0001,010,493,000,000980,556,000,000857,782,000,000822,915,000,000749,273,000,000717,078,000,000708,660,000,000591,012,000,000451,223,000,000539,612,000,000628,105,000,000717,245,000,000
Net income
32.57b
-27.53%
24,141,000,00028,944,000,00054,824,000,00075,483,000,00028,055,000,000-12,615,000,00027,312,000,00059,305,000,00042,459,000,00046,824,000,00018,364,000,00022,192,000,0003,967,000,00034,772,000,00066,513,000,0007,693,000,000-34,497,000,00042,679,000,00044,944,000,00032,570,000,000
CFO
30.77b
+205,013.33%
47,128,000,00063,744,000,00083,200,000,000120,839,000,00010,112,000,000103,497,000,000123,613,000,00015,073,000,00051,890,000,000114,185,000,00071,309,000,000105,214,000,00097,342,000,000125,082,000,00068,901,000,00016,419,000,0004,966,000,00031,351,000,00015,000,00030,767,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 06, 2025

Profile

Nikon Corporation manufactures and sells optical instruments in Japan, North America, Europe, China, Thailand, and internationally. It operates through Imaging Products Business, Precision Equipment Business, Healthcare Business, Components Business, and Industrial Metrology and Others segments. The Imaging Products Business segment provides digital SLR cameras, compact digital cameras, and interchangeable camera lenses. The Precision Equipment Business segment offers FPD lithography systems and semiconductor lithography systems. The Healthcare Business segment provides biological microscopes, cell culture observation systems, and ultra-wide field retinal imaging devices, as well as products and services related to the contract cell development and manufacturing field. The Components Business segment offers optical components, optical parts, encoders, and material processing products and services; EUV-related components and space-related solutions; and photomask substrates for FPDs. The Industrial Metrology and Others segment provides industrial microscopes, non-contact 3D metrology systems, measuring instruments, X-ray/CT inspection systems, and surveying instruments. The company also offers optical lenses, sport optics products, optical glasses, molded optical glasses, camera components, and ophthalmic lenses. In addition, it sells used equipment; provides maintenance services for FPD/semiconductor lithography systems; sells and services cameras, microscopes, measuring instruments, and X-ray inspection equipment; and develops and supports computer software. Further, the company is involved in the procurement, logistics, and employee welfare activities; development, manufacturing, and testing services for cell-based therapeutics; and assembly of camera units. Nikon Corporation was incorporated in 1917 and is headquartered in Tokyo, Japan.
URL
https://www.jp.nikon.com/
IPO date
May 16, 1949
Employees
18,790
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
717,245,000
14.19%
628,105,000
16.40%
539,612,000
19.59%
Cost of revenue
661,434,000
658,380,000
568,045,000
Unusual Expense (Income)
NOPBT
55,811,000
(30,275,000)
(28,433,000)
NOPBT Margin
7.78%
Operating Taxes
10,535,000
13,775,000
14,843,000
Tax Rate
18.88%
NOPAT
45,276,000
(44,050,000)
(43,276,000)
Net income
32,570,000
-27.53%
44,944,000
5.31%
42,679,000
-223.72%
Dividends
(17,310,000)
(14,522,000)
(11,024,000)
Dividend yield
3.25%
2.98%
2.27%
Proceeds from repurchase of equity
(3,000)
(23,797,000)
5,732,000
BB yield
0.00%
4.88%
-1.18%
Debt
Debt current
88,313,000
26,395,000
37,347,000
Long-term debt
95,784,000
124,459,000
108,875,000
Deferred revenue
28,824,000
26,917,000
Other long-term liabilities
36,579,000
2,777,000
2,687,000
Net debt
(121,893,000)
(173,235,000)
(338,101,000)
Cash flow
Cash from operating activities
30,767,000
15,000
31,351,000
CAPEX
(55,215,000)
(33,023,000)
(23,825,000)
Cash from investing activities
(41,405,000)
(112,146,000)
(385,000)
Cash from financing activities
(8,938,000)
(56,210,000)
(26,151,000)
FCF
(57,115,000)
(145,510,000)
(88,000,000)
Balance
Cash
206,644,000
212,579,000
371,225,000
Long term investments
99,346,000
111,510,000
113,098,000
Excess cash
270,127,750
292,683,750
457,342,400
Stockholders' equity
691,492,000
1,210,974,000
1,166,354,000
Invested Capital
618,248,250
482,442,250
297,519,600
ROIC
8.23%
ROCE
6.17%
EV
Common stock shares outstanding
348,234
360,200
369,263
Price
1,531.00
12.99%
1,355.00
3.12%
1,314.00
26.96%
Market cap
533,146,254
9.24%
488,071,000
0.59%
485,211,582
27.69%
EV
412,550,254
910,188,000
744,870,582
EBITDA
91,477,000
(1,219,000)
(3,576,000)
EV/EBITDA
4.51
Interest
7,834,000
5,921,000
3,643,000
Interest/NOPBT
14.04%